Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Buti

Showing results (1-10 of 386) with videos related to

Pageof 39
Sort By:
Alimentary Pharmacology & Therapeutics|September 2, 2025
Letter: "Tenofovir Alafenamide-The 'Star of Potential' for Long-Term Chronic Hepatitis B Treatment. A Deep-Dive Analysis of Phase 3 Clinical Trials." Authors' ReplyMaria Buti,
Annals of Hepatology|April 30, 2004
Current therapies for chronic hepatitis BMaria Buti
Idrugs : the Investigational Drugs Journal|April 2, 2008
Hepatitis B and C virus resistance to antiviral therapies--EASL-AASLD-APASL-ALEH-IASL conferenceMaria Buti
Liver International : Official Journal of the International Association for the Study of the Liver|December 31, 2013
HBeAg-positive chronic hepatitis B: why do i treat my patients with Nucleos(t)ide analogs?Maria Buti
Nature Reviews. Gastroenterology & Hepatology|July 26, 2022
Hepatitis D virus: more attention neededMaria Buti
Medicina Clinica|May 16, 2003
[Medical specialties in Spain: a window to modernization?]Maria Buti
Nature Clinical Practice. Gastroenterology & Hepatology|July 24, 2008
Is telbivudine superior to lamivudine for the treatment of patients with chronic hepatitis B?Maria Buti
Enfermedades Infecciosas Y Microbiologia Clinica|March 25, 2008
[Is the type of pegylated interferon important for response to treatment in patients with chronic hepatitis C infection?]Maria Buti
Enfermedades Infecciosas Y Microbiologia Clinica|November 29, 2011
[New agents for the treatment of hepatitis C]Maria Buti, Maria Homs
Drugs|July 22, 2005
Drugs in development for hepatitis BMaria Buti, Rafael Esteban
Pageof 39

Showing results (1-10 of 386) with videos related to

Sort By:
Pageof 39
Alimentary Pharmacology & Therapeutics|September 2, 2025
Letter: "Tenofovir Alafenamide-The 'Star of Potential' for Long-Term Chronic Hepatitis B Treatment. A Deep-Dive Analysis of Phase 3 Clinical Trials." Authors' ReplyMaria Buti,
Annals of Hepatology|April 30, 2004
Current therapies for chronic hepatitis BMaria Buti
Idrugs : the Investigational Drugs Journal|April 2, 2008
Hepatitis B and C virus resistance to antiviral therapies--EASL-AASLD-APASL-ALEH-IASL conferenceMaria Buti
Liver International : Official Journal of the International Association for the Study of the Liver|December 31, 2013
HBeAg-positive chronic hepatitis B: why do i treat my patients with Nucleos(t)ide analogs?Maria Buti
Nature Reviews. Gastroenterology & Hepatology|July 26, 2022
Hepatitis D virus: more attention neededMaria Buti
Medicina Clinica|May 16, 2003
[Medical specialties in Spain: a window to modernization?]Maria Buti
Nature Clinical Practice. Gastroenterology & Hepatology|July 24, 2008
Is telbivudine superior to lamivudine for the treatment of patients with chronic hepatitis B?Maria Buti
Enfermedades Infecciosas Y Microbiologia Clinica|March 25, 2008
[Is the type of pegylated interferon important for response to treatment in patients with chronic hepatitis C infection?]Maria Buti
Enfermedades Infecciosas Y Microbiologia Clinica|November 29, 2011
[New agents for the treatment of hepatitis C]Maria Buti, Maria Homs
Drugs|July 22, 2005
Drugs in development for hepatitis BMaria Buti, Rafael Esteban
Pageof 39